356 J ournal of Natural Products, 1998, Vol. 61, No. 3
Park and Kim
ck); 10 mm × 25 cm, solvent; hexane-diethyl ether 1:1,
flow rate; 3.0 mL/min, UV detector; at 240 nm. The
major products 2 and 3 have been described else-
where.7,8
m, H-5b), 2.35 (2H, m, H-6), 2.37 (1H, m, H-4), 2.53 (1H,
d, J ) 4.6 Hz, H-9a), 2.59 (1H, d, J ) 4.6 Hz, H-9b),
5.87 (1H, m, H-2); 13C NMR (CDCl3, 100 MHz) δ 21.31
(C-10), 24.12 (C-7), 24.75 (C-5), 30.67 (C-6), 50.89 (C-
4), 50.92 (C-9), 56.40 (C-8), 126.84 (C-2), 162.00 (C-1),
198.40 (C-3); EIMS m/z [M]+ 166 (19), [M - H2O]+ 148
(19), 136 (24), 121 (30), 108 (27), 93 (28), 82 ([C5H6O]+,
100), 67 (12); HREIMS m/z 166.0990 (calcd for C10H14O2
166.0994).
Con ver sion of 4 in to 4-Hyd r oxym en th on es 9 a n d
10. (+)-(4S)-4-Hydroxyisopiperitenone (4) (3 mg) was
dissolved in 2 mL of hexane, and 10 mg of Pd/C was
added. The suspension was stirred for 12 h under 1 atm
of H2. The suspension was filtered, and the filtrate
was evaporated. The residue contained a mixture of
(1R,4S)-4-hydroxymenthone (9) and (1S,4S)-4-hydroxy-
menthone (10). The structures of 9 and 10 were
identified by careful comparison of NMR data with
reported values.10-12
(+)-(4S)-4-Hyd r oxyisop ip er iten on e (4): colorless
oil (7 mg); [R]20 +136° (c 0.05, CH2Cl2); UV (MeOH)
D
λ
max (log ꢀ) 236 (4.3) nm; IR (neat) νmax 3475, 2930, 1670
cm-1; H NMR (CDCl3, 400 MHz) δ 1.84 (3H, s, H-10),
1.95 (1H, m, H-5a), 1.96 (3H, s, H-7), 2.30 (2H, m, H-6),
2.33 (1H, m, H-5b), 3.78 (1H, s, OH-4), 4.69 (1H, m,
H-9a), 4.94 (1H, m, H-9b), 5.98 (1H, m, H-2); 13C NMR
(CDCl3, 100 MHz) δ 18.09 (C-10), 24.22 (C-7), 29.97 (C-
6), 32.62 (C-5), 77.14 (C-4), 113.49 (C-9), 124.42 (C-2),
144.36 (C-8), 164.22 (C-1), 201.16 (C-3); EIMS m/z [M]+
166 (5), [M - H2O]+ 148 (59), 133 (32), 105 (46), 97 (22),
82 ([C5H6O]+, 100), 69 (16); HREIMS m/z 166.0974
(calcd for C10H14O2 166.0994).
1
(-)-(4R,6R)-6-Hyd r oxyisop ip er iten on e (5): color-
less oil (8 mg); [R]20D -7.2° (c 0.08, CH2Cl2); UV (MeOH)
Con ver sion of (-)-(4S)-Lim on en e (12) in t o
(4S,8R)- a n d (4S,8S)-Ep oxy-p-m en th -1-en e (15 a n d
16). Compounds 15 and 16 were prepared according
to the known procedure starting from 12.13 1H and 13C
NMR data of the intermediates (11, 13-16) were
identical to those of the enantiomers13 except for the
sign of optical rotation.
λ
max (log ꢀ) 231 (3.9) nm; IR (neat) νmax 3310, 2940, 1640
cm-1; H NMR (CDCl3, 400 MHz) δ 1.74 (3H, s, H-10),
2.06 (3H, s, H-7), 2.14 (1H, ddd, J ) 12.4, 13.6, 10.2
Hz, H-5ax), 2.31 (1H, ddd, J ) 12.4, 4.5, 4.7 Hz, H-5eq),
2.46 (1H, br s, -OH), 3.05 (1H, dd, J ) 13.6, 4.5 Hz,
H-4), 4.51 (1H, br. s, H-6), 4.81 (1H, m, H-9a), 4.98 (1H,
m, H-9b), 5.88 (1H, m, H-2); 13C NMR (CDCl3, 100 MHz)
δ 19.67 (C-7), 19.94 (C-10), 37.94 (C-5), 53.88 (C-4), 69.74
(C-6), 114.49 (C-9), 126.82 (C-2), 143.00 (C-8), 163.82
(C-1), 198.21 (C-3); EIMS m/z [M]+ 166 (8), [M - H2O]+
148 (27), 133 (16), 105 (22), 98 ([C5H6O2]+, 100), 69 (46);
HREIMS m/z 166.0990 (calcd for C10H14O2 166.0994).
1
(1R,2R,4S)-1,2-Dibr om o-p-m en th -8-en e (11): [R]20
-57.0° (c 0.2, CH2Cl2).
D
(1R ,2R ,4S ,8R )-1,2-Dib r om o-8,9-e p ox y-p -m e n -
th a n e (13): [R]20 -61.7° (c 0.6, CH2Cl2).
D
(1R ,2R ,4S ,8S )-1,2-D ib r o m o -8,9-e p o x y -p -m e n -
th a n e (14): [R]20 -50.8° (c 0.34, CH2Cl2).
(+)-(4R,6S)-6-Hyd r oxyisop ip er iten on e (6): white
D
(4S,8R)-8,9-Epoxy-p-m en th -1-en e (15): [R]20D -83.6°
(c 0.47, CH2Cl2).
powder (8 mg); [R]20 +17.4° (c 0.08, CH2Cl2); UV
D
(MeOH) λmax (log ꢀ) 231 (3.9) nm; IR (KBr) νmax 3410,
2920, 1660 cm-1; 1H NMR (CDCl3, 400 MHz) δ 1.77 (3H,
s, H-10), 2.05 (3H, s, H-7) 2.39 (1H, ddd, J ) 13.6, 9.1,
4.2 Hz, H-5ax), 2.10 (1H, ddd, J ) 13.6, 4.8, 5.6 Hz,
H-5eq), 3.30 (1H, dd, J ) 9.1, 4.8 Hz, H-4), 4.35 (1H, br
s, H-6), 4.76 (1H, m, H-9a), 4.96 (1H, m, H-9b), 5.88 (1H,
m, H-2); 13C NMR (CDCl3, 100 MHz) δ 20.96 (C-7), 21.08
(C-10), 36.11 (C-5), 50.01 (C-4), 67.28 (C-6), 113.73 (C-
9), 127.29 (C-2), 142.42 (C-8), 159.82 (C-1), 198.81 (C-
3); EIMS m/z [M]+ 166 (10), [M - H2O]+ 148 (58), 133
(35), 105 (47), 98 (C5H6O2+, 100), 69 (46): HREIMS m/z
166.0996 (calcd for C10H14O2 166.0994).
(4S,8S)-8,9-Epoxy-p-m en th -1-en e (16): [R]20D -77.7°
(c 0.14, CH2Cl2).
Con ver sion of 15 a n d 16 in to 8,9-Ep oxyisop ip -
er iten on es (7 a n d 8). t-BuOOH (90%, 1.3 mL) was
added to a solution of CrO3 (5 mg) in CH2Cl2 (5 mL).
The epoxide (152 mg, 15 or 16) in CH2Cl2 (1 mL) was
then added dropwise and stirred for 2 h at room
temperature. The solution was successively washed
with saturated aqueous NaHCO3 and brine and then
finally dried over MgSO4 and evaporated. The product
was separated using preparative TLC (hexane-diethyl
ether 5:1; multiple developments). Synthetic 8,9-ep-
oxyisopiperitenones (7 and 8) showed the same physi-
cochemical properties as the isolates from cell culture.
(-)-(4R,8R)-8,9-Ep oxyisop ip er iten on e (7): color-
less oil (10 mg); [R]20 -110.0° (c 0.70, CH2Cl2); UV
D
(MeOH) λmax (log ꢀ) 235 (4.1) nm; IR (neat) νmax 2930,
1670, 1200 cm-1; 1H NMR (CDCl3, 400 MHz) δ 1.26 (3H,
s, H-10), 1.97 (3H, s, H-7), 2.01 (1H, m, H-4), 2.04 (1H,
m, H-5a), 2.24 (1H, m, H-5b), 2.37 (2H, m, H-6), 2.73
(1H, d, J ) 4.5 Hz, H-9a), 2.82 (1H, d, J ) 4.5 Hz, H-9b),
5.87 (1H, m, H-2); 13C NMR (CDCl3, 100 MHz) δ 17.15
(C-10), 24.08 (C-7), 24.78 (C-5), 30.81 (C-6), 53.44 (C-
4), 55.77 (C-9), 56.57 (C-8), 126.45 (C-2), 162.40 (C-1),
197.82 (C-3); EIMS m/z [M]+ 166 (19), [M - H2O]+ 148
(19), 136 (24), 121 (30), 108 (28), 93 (30), 82 ([C5H6O]+,
100), 67 (13); HREIMS m/z 166.0984 (calcd for C10H14O2
166.0994).
Ack n ow led gm en t. This work was supported by a
grant from the Korea Science and Engineering Founda-
tion through The Research Center for New Bio-Materi-
als in Agriculture. S.U.K. thanks his wife Sang-Ok for
manuscript preparation.
Refer en ces a n d Notes
(1) Hirata, T.; Murakami, S.; Ogihara, K.; Suga, T. Phytochemistry
1990, 29, 493-495.
(2) Kato, A.; Kawazoe, S.; Iijima, M.; Shimizu, Y. J . Ferment.
Technol. 1976, 54, 82-87.
(3) Aviv, D.; Galun, E. Planta Med. 1978, 33, 70-77.
(4) Aviv, D.; Krochmal, E.; Dantes, A.; Galun, E. Planta Med. 1981,
42, 236-243.
(-)-(4R,8S)-8,9-Ep oxyisop ip er iten on e (8): color-
less oil (4 mg); [R]20 -41.2° (c 0.20, CH2Cl2); UV
D
(5) Galun, E.; Aviv, D.; Dantes, A.; Freeman, A. Planta Med. 1985,
51, 511-514.
(MeOH) λmax (log ꢀ) 234 (4.1) nm; IR (neat) νmax 2930,
1670, 1200 cm-1; 1H NMR (CDCl3, 400 MHz) δ 1.44 (3H,
s, H-10), 1.74 (1H, m, H-5a), 1.95 (3H, s, H-7), 2.08 (1H,
(6) Park, S.-H.; Chae, Y.-A.; Lee, H. J .; Kim, S.-U. J . Korean Agric.
Chem. Soc. 1993, 36, 358-363.